← SynDRA
TREPROSTINIL
SynDRA canonical compound SYN0024426 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGIR |
|---|
| Mechanism of action | Platelet aggregation inhibitor |
|---|
| Indication | pulmonary arterial hypertension (PAH) |
|---|
| Disease area | pulmonary |
|---|
All known targets
- PTGIR
- PTGDR
- PTGER2
- P2RY12
- PPARD
- PTGER1
- PTGER3
- PTGER4
Mechanisms of action (all sources)
- Prostanoid receptor agonist
- Platelet aggregation inhibitor
- PTGIR AGONIST
- Prostanoid IP receptor agonist
Drug classes
- Prostacycline Vasodilator
- Antihypertensive Agents
- Cardiovascular Agents
ATC classes
- B01A · ANTITHROMBOTIC AGENTS
Cross-references
Synonyms
- treprost
- uniprost
- treprostinil sodium
- 15AU81
- LRX-15
- UT-15
- treprostinil diolamine
- Tresprostinil
- Treprostinilo
- Rumodolin
- Uniprost
- 15-AU-81
- L-606
- L606
- Remodulin
- Tyvaso
- Tyvaso dpi
- Treprostinilum
- Viveta
- Treprostinil sodium
- LRX 15
- U 62840
- Remodulin (TN)
- Treprostinil [USAN:INN]
- Treprostinil (USAN/INN)
- U-62,840
- ((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate
- ({(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl}oxy)acetic acid
- 15 AU81
- 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
- 2-[[(1S,2S,3aR,9aR)-2-hydroxy-1-[(3R)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
- MRE-269
- treprostinil phosphate
- RUM6K67ESG
- treprostinilo
- treprostinilum
- CHEBI:50861
- trepostinil sodium
Reported adverse events
- Headache
- Rash
- Infection
- Vasodilatation
- Infusion
- Pain
- Nausea
- Infusion site reaction
- Flushing
- Syncope
- Cough
- Hypertension
Look up TREPROSTINIL in the interactive SynDRA portal →